Global Extracorporeal Life Support Devices Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027
Date: Apr-2021 | Id: MACRC-52017 | Geographical Scope: Global | Publisher: HNY Research
The global Extracorporeal Life Support Devices market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). By Market Verdors: Medtronic Getinge Sorin Group MAQUET Holding MedosMedizintechnik Microport Scientific SynCardia Terumo Cardiovascular Systems Nipro Medical BiVACOR Jarvik Heart CARMAT AbioMed By Types: Venoarterial (VA) ECMO Venovenous (VV) ECMO By Applications: Hospital Clinic Other Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Extracorporeal Life Support Devices Revenue 1.5 Market Analysis by Type 1.5.1 Global Extracorporeal Life Support Devices Market Size Growth Rate by Type: 2021 VS 2027 1.5.2 Venoarterial (VA) ECMO 1.5.3 Venovenous (VV) ECMO 1.6 Market by Application 1.6.1 Global Extracorporeal Life Support Devices Market Share by Application: 2022-2027 1.6.2 Hospital 1.6.3 Clinic 1.6.4 Other 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Extracorporeal Life Support Devices Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter’s Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Extracorporeal Life Support Devices Market Players Profiles 3.1 Medtronic 3.1.1 Medtronic Company Profile 3.1.2 Medtronic Extracorporeal Life Support Devices Product Specification 3.1.3 Medtronic Extracorporeal Life Support Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.2 Getinge 3.2.1 Getinge Company Profile 3.2.2 Getinge Extracorporeal Life Support Devices Product Specification 3.2.3 Getinge Extracorporeal Life Support Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.3 Sorin Group 3.3.1 Sorin Group Company Profile 3.3.2 Sorin Group Extracorporeal Life Support Devices Product Specification 3.3.3 Sorin Group Extracorporeal Life Support Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.4 MAQUET Holding 3.4.1 MAQUET Holding Company Profile 3.4.2 MAQUET Holding Extracorporeal Life Support Devices Product Specification 3.4.3 MAQUET Holding Extracorporeal Life Support Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.5 MedosMedizintechnik 3.5.1 MedosMedizintechnik Company Profile 3.5.2 MedosMedizintechnik Extracorporeal Life Support Devices Product Specification 3.5.3 MedosMedizintechnik Extracorporeal Life Support Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.6 Microport Scientific 3.6.1 Microport Scientific Company Profile 3.6.2 Microport Scientific Extracorporeal Life Support Devices Product Specification 3.6.3 Microport Scientific Extracorporeal Life Support Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.7 SynCardia 3.7.1 SynCardia Company Profile 3.7.2 SynCardia Extracorporeal Life Support Devices Product Specification 3.7.3 SynCardia Extracorporeal Life Support Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.8 Terumo Cardiovascular Systems 3.8.1 Terumo Cardiovascular Systems Company Profile 3.8.2 Terumo Cardiovascular Systems Extracorporeal Life Support Devices Product Specification 3.8.3 Terumo Cardiovascular Systems Extracorporeal Life Support Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.9 Nipro Medical 3.9.1 Nipro Medical Company Profile 3.9.2 Nipro Medical Extracorporeal Life Support Devices Product Specification 3.9.3 Nipro Medical Extracorporeal Life Support Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.10 BiVACOR 3.10.1 BiVACOR Company Profile 3.10.2 BiVACOR Extracorporeal Life Support Devices Product Specification 3.10.3 BiVACOR Extracorporeal Life Support Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.11 Jarvik Heart 3.11.1 Jarvik Heart Company Profile 3.11.2 Jarvik Heart Extracorporeal Life Support Devices Product Specification 3.11.3 Jarvik Heart Extracorporeal Life Support Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.12 CARMAT 3.12.1 CARMAT Company Profile 3.12.2 CARMAT Extracorporeal Life Support Devices Product Specification 3.12.3 CARMAT Extracorporeal Life Support Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.13 AbioMed 3.13.1 AbioMed Company Profile 3.13.2 AbioMed Extracorporeal Life Support Devices Product Specification 3.13.3 AbioMed Extracorporeal Life Support Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021) 4 Global Extracorporeal Life Support Devices Market Competition by Market Players 4.1 Global Extracorporeal Life Support Devices Production Capacity Market Share by Market Players (2016-2021) 4.2 Global Extracorporeal Life Support Devices Revenue Market Share by Market Players (2016-2021) 4.3 Global Extracorporeal Life Support Devices Average Price by Market Players (2016-2021) 5 Global Extracorporeal Life Support Devices Production by Regions (2016-2021) 5.1 North America 5.1.1 North America Extracorporeal Life Support Devices Market Size (2016-2021) 5.1.2 Extracorporeal Life Support Devices Key Players in North America (2016-2021) 5.1.3 North America Extracorporeal Life Support Devices Market Size by Type (2016-2021) 5.1.4 North America Extracorporeal Life Support Devices Market Size by Application (2016-2021) 5.2 East Asia 5.2.1 East Asia Extracorporeal Life Support Devices Market Size (2016-2021) 5.2.2 Extracorporeal Life Support Devices Key Players in East Asia (2016-2021) 5.2.3 East Asia Extracorporeal Life Support Devices Market Size by Type (2016-2021) 5.2.4 East Asia Extracorporeal Life Support Devices Market Size by Application (2016-2021) 5.3 Europe 5.3.1 Europe Extracorporeal Life Support Devices Market Size (2016-2021) 5.3.2 Extracorporeal Life Support Devices Key Players in Europe (2016-2021) 5.3.3 Europe Extracorporeal Life Support Devices Market Size by Type (2016-2021) 5.3.4 Europe Extracorporeal Life Support Devices Market Size by Application (2016-2021) 5.4 South Asia 5.4.1 South Asia Extracorporeal Life Support Devices Market Size (2016-2021) 5.4.2 Extracorporeal Life Support Devices Key Players in South Asia (2016-2021) 5.4.3 South Asia Extracorporeal Life Support Devices Market Size by Type (2016-2021) 5.4.4 South Asia Extracorporeal Life Support Devices Market Size by Application (2016-2021) 5.5 Southeast Asia 5.5.1 Southeast Asia Extracorporeal Life Support Devices Market Size (2016-2021) 5.5.2 Extracorporeal Life Support Devices Key Players in Southeast Asia (2016-2021) 5.5.3 Southeast Asia Extracorporeal Life Support Devices Market Size by Type (2016-2021) 5.5.4 Southeast Asia Extracorporeal Life Support Devices Market Size by Application (2016-2021) 5.6 Middle East 5.6.1 Middle East Extracorporeal Life Support Devices Market Size (2016-2021) 5.6.2 Extracorporeal Life Support Devices Key Players in Middle East (2016-2021) 5.6.3 Middle East Extracorporeal Life Support Devices Market Size by Type (2016-2021) 5.6.4 Middle East Extracorporeal Life Support Devices Market Size by Application (2016-2021) 5.7 Africa 5.7.1 Africa Extracorporeal Life Support Devices Market Size (2016-2021) 5.7.2 Extracorporeal Life Support Devices Key Players in Africa (2016-2021) 5.7.3 Africa Extracorporeal Life Support Devices Market Size by Type (2016-2021) 5.7.4 Africa Extracorporeal Life Support Devices Market Size by Application (2016-2021) 5.8 Oceania 5.8.1 Oceania Extracorporeal Life Support Devices Market Size (2016-2021) 5.8.2 Extracorporeal Life Support Devices Key Players in Oceania (2016-2021) 5.8.3 Oceania Extracorporeal Life Support Devices Market Size by Type (2016-2021) 5.8.4 Oceania Extracorporeal Life Support Devices Market Size by Application (2016-2021) 5.9 South America 5.9.1 South America Extracorporeal Life Support Devices Market Size (2016-2021) 5.9.2 Extracorporeal Life Support Devices Key Players in South America (2016-2021) 5.9.3 South America Extracorporeal Life Support Devices Market Size by Type (2016-2021) 5.9.4 South America Extracorporeal Life Support Devices Market Size by Application (2016-2021) 5.10 Rest of the World 5.10.1 Rest of the World Extracorporeal Life Support Devices Market Size (2016-2021) 5.10.2 Extracorporeal Life Support Devices Key Players in Rest of the World (2016-2021) 5.10.3 Rest of the World Extracorporeal Life Support Devices Market Size by Type (2016-2021) 5.10.4 Rest of the World Extracorporeal Life Support Devices Market Size by Application (2016-2021) 6 Global Extracorporeal Life Support Devices Consumption by Region (2016-2021) 6.1 North America 6.1.1 North America Extracorporeal Life Support Devices Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Extracorporeal Life Support Devices Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Extracorporeal Life Support Devices Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Extracorporeal Life Support Devices Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Extracorporeal Life Support Devices Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Extracorporeal Life Support Devices Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Extracorporeal Life Support Devices Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Extracorporeal Life Support Devices Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Extracorporeal Life Support Devices Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Extracorporeal Life Support Devices Consumption by Countries 7 Global Extracorporeal Life Support Devices Production Forecast by Regions (2022-2027) 7.1 Global Forecasted Production of Extracorporeal Life Support Devices (2022-2027) 7.2 Global Forecasted Revenue of Extracorporeal Life Support Devices (2022-2027) 7.3 Global Forecasted Price of Extracorporeal Life Support Devices (2022-2027) 7.4 Global Forecasted Production of Extracorporeal Life Support Devices by Region (2022-2027) 7.4.1 North America Extracorporeal Life Support Devices Production, Revenue Forecast (2022-2027) 7.4.2 East Asia Extracorporeal Life Support Devices Production, Revenue Forecast (2022-2027) 7.4.3 Europe Extracorporeal Life Support Devices Production, Revenue Forecast (2022-2027) 7.4.4 South Asia Extracorporeal Life Support Devices Production, Revenue Forecast (2022-2027) 7.4.5 Southeast Asia Extracorporeal Life Support Devices Production, Revenue Forecast (2022-2027) 7.4.6 Middle East Extracorporeal Life Support Devices Production, Revenue Forecast (2022-2027) 7.4.7 Africa Extracorporeal Life Support Devices Production, Revenue Forecast (2022-2027) 7.4.8 Oceania Extracorporeal Life Support Devices Production, Revenue Forecast (2022-2027) 7.4.9 South America Extracorporeal Life Support Devices Production, Revenue Forecast (2022-2027) 7.4.10 Rest of the World Extracorporeal Life Support Devices Production, Revenue Forecast (2022-2027) 7.5 Forecast by Type and by Application (2022-2027) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027) 7.5.2 Global Forecasted Consumption of Extracorporeal Life Support Devices by Application (2022-2027) 8 Global Extracorporeal Life Support Devices Consumption Forecast by Regions (2022-2027) 8.1 North America Forecasted Consumption of Extracorporeal Life Support Devices by Country 8.2 East Asia Market Forecasted Consumption of Extracorporeal Life Support Devices by Country 8.3 Europe Market Forecasted Consumption of Extracorporeal Life Support Devices by Countriy 8.4 South Asia Forecasted Consumption of Extracorporeal Life Support Devices by Country 8.5 Southeast Asia Forecasted Consumption of Extracorporeal Life Support Devices by Country 8.6 Middle East Forecasted Consumption of Extracorporeal Life Support Devices by Country 8.7 Africa Forecasted Consumption of Extracorporeal Life Support Devices by Country 8.8 Oceania Forecasted Consumption of Extracorporeal Life Support Devices by Country 8.9 South America Forecasted Consumption of Extracorporeal Life Support Devices by Country 8.10 Rest of the world Forecasted Consumption of Extracorporeal Life Support Devices by Country 9 Global Extracorporeal Life Support Devices Sales by Type (2016-2027) 9.1 Global Extracorporeal Life Support Devices Historic Market Size by Type (2016-2021) 9.2 Global Extracorporeal Life Support Devices Forecasted Market Size by Type (2022-2027) 10 Global Extracorporeal Life Support Devices Consumption by Application (2016-2027) 10.1 Global Extracorporeal Life Support Devices Historic Market Size by Application (2016-2021) 10.2 Global Extracorporeal Life Support Devices Forecasted Market Size by Application (2022-2027) 11 Global Extracorporeal Life Support Devices Manufacturing Cost Analysis 11.1 Extracorporeal Life Support Devices Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Extracorporeal Life Support Devices 12 Global Extracorporeal Life Support Devices Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Extracorporeal Life Support Devices Distributors List 12.3 Extracorporeal Life Support Devices Customers 12.4 Extracorporeal Life Support Devices Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
Related reports
Non-Hodgkin Lymphoma Therapeutics Market
$2000-$6000
Acrylic Teeth Market
$3600-$7000